Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV

Overview of attention for article published in Frontiers in immunology, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 13 X posts from 11 X users, with an upper bound of 63,901 followers.

RT @JMartinezSanz: Nuevo trabajo colaborativo en #CoRIS! Recuperación similar de CD4/CD8 tras 48 semanas del inicio del TAR con DTG+3TC vs…

25 Apr 2022

Reply Repost Favourite

RT @JMartinezSanz: Nuevo trabajo colaborativo en #CoRIS! Recuperación similar de CD4/CD8 tras 48 semanas del inicio del TAR con DTG+3TC vs…

01 Apr 2022

Reply Repost Favourite

New Research: Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV: Background The initiation of antiretroviral treatment based… https://t.co/

01 Apr 2022

Reply Repost Favourite

RT @JMartinezSanz: Nuevo trabajo colaborativo en #CoRIS! Recuperación similar de CD4/CD8 tras 48 semanas del inicio del TAR con DTG+3TC vs…

01 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.